Literature DB >> 7936653

Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen.

F Weih1, D Carrasco, R Bravo.   

Abstract

We have studied the expression of members of the rel family of transcription factors and ikba in mouse thymus and spleen by in situ hybridization. Our results show that the rel genes have different temporal and spatial patterns of expression suggesting distinct roles in these lymphoid tissues. The Rel/NF-kappa B proteins and I kappa B alpha in thymus and spleen were also analysed by Western blotting and electrophoretic mobility shift assays. Although RelB protein is present at significantly lower levels in thymus and spleen extracts when compared to RelA, in both tissues the predominant kappa B-binding activity consists of p50/RelB and p52/RelB heterodimers and only very little binding of RelA-containing complexes to kappa B sites was detected. Significant binding of c-Rel complexes was only found in spleen extracts. Treatment of thymus and spleen extracts with deoxycholate (DOC), however, results in a strong increase in binding to kappa B sites of both RelA and c-Rel complexes. In contrast, binding of RelB complexes is not induced after DOC treatment. Our results suggest a differential role of Rel/NF-kappa B complexes in mouse thymus and spleen with RelB heterodimers representing the constitutive kappa B-binding activity, whereas RelA and c-Rel complexes most likely are involved in inducible kappa B-binding and gene activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7936653

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

1.  Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus.

Authors:  F K Yoshimura; T Wang; M Cankovic
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  NF-kappaB2 is required for the control of autoimmunity by regulating the development of medullary thymic epithelial cells.

Authors:  Baochun Zhang; Zhe Wang; Jane Ding; Pärt Peterson; William T Gunning; Han-Fei Ding
Journal:  J Biol Chem       Date:  2006-10-17       Impact factor: 5.157

3.  Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.

Authors:  J H Caamaño; P Perez; S A Lira; R Bravo
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  Identification of nucleotide sequences that regulate transcription of the MCF13 murine leukemia virus long terminal repeat in activated T cells.

Authors:  F K Yoshimura; M Cankovic; R Smeltz; S Ibrahim
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 5.  Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation.

Authors:  R S Smith; T J Smith; T M Blieden; R P Phipps
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

6.  Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes.

Authors:  Xiaobo Wang; Gail E Sonenshein
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

7.  The nfkb1 promoter is controlled by proteins of the Ets family.

Authors:  P F Lambert; M J Ludford-Menting; N J Deacon; I Kola; R R Doherty
Journal:  Mol Biol Cell       Date:  1997-02       Impact factor: 4.138

8.  Novel protein antigen (JHP940) from the genomic plasticity region of Helicobacter pylori induces tumor necrosis factor alpha and interleukin-8 secretion by human macrophages.

Authors:  Mohammed Rizwan; Ayesha Alvi; Niyaz Ahmed
Journal:  J Bacteriol       Date:  2007-11-09       Impact factor: 3.490

9.  Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway.

Authors:  F Weih; R P Ryseck; L Chen; R Bravo
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

10.  High-level replication of human immunodeficiency virus in thymocytes requires NF-kappaB activation through interaction with thymic epithelial cells.

Authors:  L Chêne; M T Nugeyre; F Barré-Sinoussi; N Israël
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.